My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 12

    1.

    Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course.

    Put N, Van Roosbroeck K, Konings P, Meeus P, Brusselmans C, Rack K, Gervais C, Nguyen-Khac F, Chapiro E, Radford-Weiss I, Struski S, Dastugue N, Gachard N, Lefebvre C, Barin C, Eclache V, Fert-Ferrer S, Laibe S, Mozziconacci MJ, Quilichini B, Poirel HA, Wlodarska I, Hagemeijer A, Moreau Y, Vandenberghe P, Michaux L; on behalf of the BCGHo and the GFCH.

    Ann Hematol. 2012 Jun;91(6):863-873. Epub 2011 Dec 30.

    PMID:
    22205151
    [PubMed - as supplied by publisher]

    Related citations

    2.

    Prognostic value of monosomal karyotype in comparison to complex aberrant karyotype in acute myeloid leukemia: a study on 824 cases with aberrant karyotype.

    Haferlach C, Alpermann T, Schnittger S, Kern W, Chromik J, Schmid C, Pielken HJ, Kreuzer KA, Höffkes HG, Haferlach T.

    Blood. 2012 Mar 1;119(9):2122-5. Epub 2011 Dec 29.

    PMID:
    22207733
    [PubMed - indexed for MEDLINE]

    Related citations

    3.

    MTHFR 677TT genotype and toxicity of methotrexate: controversial results.

    Lopez-Lopez E, Ballesteros J, Garcia-Orad A.

    Cancer Chemother Pharmacol. 2011 Nov;68(5):1369-70; author reply 1371. Epub 2011 Aug 6. No abstract available.

    PMID:
    21822667
    [PubMed - indexed for MEDLINE]

    Related citations

    4.

    Resistance of leukemic stem-like cells in AML cell line KG1a to natural killer cell-mediated cytotoxicity.

    She M, Niu X, Chen X, Li J, Zhou M, He Y, Le Y, Guo K.

    Cancer Lett. 2012 May 28;318(2):173-9. doi: 10.1016/j.canlet.2011.12.017. Epub 2011 Dec 21.

    PMID:
    22198207
    [PubMed - indexed for MEDLINE]

    Related citations

    5.

    β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3).

    Lamoth F, Cruciani M, Mengoli C, Castagnola E, Lortholary O, Richardson M, Marchetti O; Third European Conference on Infections in Leukemia (ECIL-3).

    Clin Infect Dis. 2012 Mar 1;54(5):633-43. Epub 2011 Dec 23.

    PMID:
    22198786
    [PubMed - in process]

    Related citations

    6.

    First-line treatment with imatinib mesylate in patients with chronic phase chronic myeloid leukemia: experience of a public hospital in a developing country of South America.

    da Silveira CA, Ferrari I.

    Leuk Lymphoma. 2012 Jan 31. [Epub ahead of print] No abstract available.

    PMID:
    22204455
    [PubMed - as supplied by publisher]

    Related citations

    7.

    No evidence for DNA methylation of the ATM promoter CpG island in chronic lymphocytic leukemia.

    Mikeska T, Carney DA, Seymour JF, Dobrovic A.

    Leuk Lymphoma. 2012 Jan 31. [Epub ahead of print] No abstract available.

    PMID:
    22204453
    [PubMed - as supplied by publisher]

    Related citations

    8.

    Azacitidine in a patient with newly diagnosed acute myeloid leukemia and poor risk cytogenetics: outcomes of prolonged therapy.

    Pappa V, Girkas K, Sambani C, Pagageorgiou S, Tsirigiotis P, Karvounis K, Stathopoulou E, Economopoulos T, Dimitriadis G, Dervenoulas I.

    Leuk Res. 2012 Apr;36(4):e78-80. Epub 2011 Dec 26. No abstract available.

    PMID:
    22204783
    [PubMed - indexed for MEDLINE]

    Related citations

    9.

    The activity of the inosine triphosphate pyrophosphatase affects toxicity of 6-mercaptopurine during maintenance therapy for acute lymphoblastic leukemia in Japanese children.

    Tanaka Y, Manabe A, Nakadate H, Kondoh K, Nakamura K, Koh K, Utano T, Kikuchi A, Komiyama T.

    Leuk Res. 2012 May;36(5):560-4. Epub 2011 Dec 24.

    PMID:
    22200619
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    Comparison between multiparameter flow cytometry and WT1-RNA quantification in monitoring minimal residual disease in acute myeloid leukemia without specific molecular targets.

    Rossi G, Minervini MM, Carella AM, de Waure C, di Nardo F, Melillo L, D'Arena G, Zini G, Cascavilla N.

    Leuk Res. 2012 Apr;36(4):401-6. Epub 2011 Dec 21.

    PMID:
    22196957
    [PubMed - indexed for MEDLINE]

    Related citations

    11.

    Human cytomegalovirus activation of ERK and myeloid cell leukemia-1 protein correlates with survival of latently infected cells.

    Reeves MB, Breidenstein A, Compton T.

    Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):588-93. Epub 2011 Dec 27.

    PMID:
    22203987
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    Lymphomas that recur after MYC suppression continue to exhibit oncogene addiction.

    Choi PS, van Riggelen J, Gentles AJ, Bachireddy P, Rakhra K, Adam SJ, Plevritis SK, Felsher DW.

    Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17432-7. Epub 2011 Oct 3.

    PMID:
    21969595
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk